FIG4 Gene Amyotrophic Lateral Sclerosis Type 11 NGS Genetic DNA Test
Comprehensive Genetic Testing for Neurological Disorders
The FIG4 Gene Amyotrophic Lateral Sclerosis Type 11 NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics. This advanced testing method utilizes cutting-edge Next-Generation Sequencing (NGS) technology to identify specific mutations in the FIG4 gene that are directly associated with Amyotrophic Lateral Sclerosis Type 11, a rare but devastating form of motor neuron disease.
What This Test Measures and Detects
This comprehensive genetic analysis specifically targets the FIG4 gene, which plays a crucial role in cellular membrane trafficking and lysosomal function. The test identifies:
- Pathogenic variants in the FIG4 gene associated with ALS Type 11
- Single nucleotide polymorphisms (SNPs) affecting protein function
- Insertions, deletions, and copy number variations
- Novel mutations that may contribute to disease development
- Genetic markers that influence disease progression and severity
Who Should Consider This Test
This genetic test is particularly recommended for individuals experiencing:
- Progressive muscle weakness and atrophy
- Difficulty with speech, swallowing, or breathing
- Family history of ALS or related neurological disorders
- Early onset neurological symptoms (before age 45)
- Unexplained muscle twitching or cramping
- Progressive loss of motor function
- Individuals with known FIG4 gene mutations in their family
- Those seeking pre-symptomatic genetic testing due to family history
Key Benefits of Genetic Testing
Undergoing the FIG4 Gene ALS Type 11 test provides numerous advantages:
- Early Detection: Identify genetic risk factors before symptoms become severe
- Personalized Treatment: Enable targeted therapeutic approaches based on genetic profile
- Family Planning: Make informed decisions about family health and inheritance patterns
- Clinical Management: Guide neurologists in developing comprehensive care plans
- Research Contribution: Help advance scientific understanding of neurological disorders
- Peace of Mind: Reduce uncertainty through definitive genetic information
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our team of certified genetic counselors and neurologists. Results typically fall into three categories:
- Positive Result: Indicates the presence of a known pathogenic variant in the FIG4 gene. This confirms genetic predisposition to ALS Type 11 and enables proactive management strategies.
- Negative Result: No known pathogenic variants detected. This significantly reduces but does not completely eliminate the risk of developing ALS Type 11.
- Variant of Uncertain Significance (VUS): Identifies genetic changes whose clinical significance is currently unknown. These require ongoing monitoring and may be reclassified as research advances.
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures accessible genetic testing services nationwide.
Take Control of Your Neurological Health
Don’t wait to get the answers you need about your genetic health. Our comprehensive FIG4 Gene ALS Type 11 NGS Genetic DNA Test provides the clarity and information necessary to make informed healthcare decisions. With results available in 3-4 weeks and professional genetic counseling included, you’ll receive the expert guidance needed to understand your results and plan for the future.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic testing appointment or to speak with our genetic counseling team. Take the first step toward understanding your neurological health with confidence and precision.
